From October 1, 2023 to December 31, 2023, the company has repurchased 1,385,217 shares, representing 4.19% for $25 million. With this, the company has completed the repurchase of 3,088,069 shares, representing 9.09% for $75 million under the buyback announced on January 4, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.31 USD | -12.02% | -11.29% | +8.11% |
03:57pm | Needham Downgrades Collegium Pharmaceutical to Hold From Buy | MT |
01:26pm | Piper Downgrades Collegium Pharmaceutical to Neutral From Overweight, Price Target at $39 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.11% | 1.24B | |
+31.38% | 695B | |
+26.51% | 568B | |
-4.63% | 361B | |
+19.58% | 330B | |
+3.65% | 283B | |
+16.75% | 239B | |
+8.61% | 204B | |
-7.69% | 198B | |
+8.82% | 168B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Tranche Update on Collegium Pharmaceutical, Inc.'s Equity Buyback Plan announced on January 4, 2023.